UPDATE 1-UK Stocks-Factors to watch on Nov 27
Reuters
Published Nov 27, 2020 08:58
(Adds futures, news items)
Nov 27 - Britain's FTSE 100 .FTSE index is seen opening 19 points lower at
6,344 on Friday, according to financial bookmakers, with futures down 0.12%
ahead of the cash market open.
* ASTRAZENECA: The situation regarding the COVID-19 vaccine being developed
by AstraZeneca AZN.L is generally encouraging, even though a new trial will be
needed, said AstraZeneca France President Olivier Nataf. * ASTRAZENECA: The Philippines will get 2.6 million shots of a potential
COVID-19 vaccine developed by AstraZeneca AZN.L under the country's first
supply deal for a coronavirus vaccine, senior officials said. * GOLD: Gold eased en route to a third straight weekly drop as investors
weighed doubts over a leading COVID-19 vaccine candidate against optimism that
vaccines will arrive sooner than expected. * OIL: Oil prices were lower in quiet trade due to the U.S. Thanksgiving
holiday, dropping amid concerns about oversupply and doubts about a vaccine to
end the coronavirus pandemic. * The UK blue-chip index .FTSE closed 0.4% lower on Thursday amid
heightened concerns over economic growth after Health Minister Matt Hancock said
more than a third of the population would remain under tough COVID-19
restrictions at the end of a national lockdown. For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.